The Food and Drug Administration (FDA) plans to hold a public hearing on May 31 in Maryland to explore issues around products containing cannabis or cannabis-derived compounds such as cannabidiol (CBD).
Symptoms such as pain and nausea improved in cancer patients who took cannabis, according to new research that is part of Minnesota’s effort to address the information void about whether marijuana offers medical benefits.